Metreleptin and Lipodystrophy Data Presented at the International Meeting of Pediatric Endocrinology

file9161288616167

VANCOUVER, British Columbia and CAMBRIDGE, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) — Novelion Therapeutics Inc. (NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, today announced the …

Read more